Seborrheic Dermatitis Treatment Market Research, 2031
The global seborrheic dermatitis treatment market size was valued at $2,330.1 million in 2021, and is projected to reach $6,634.2 million by 2031, growing at a CAGR of 11.0% from 2022 to 2031. Skin conditions that are widespread, infectious, and simple to treat include seborrheic dermatitis. This type of dermatitis results in greasy scales, itchy red spots, and white, yellow, or white-like crust on the scalp. The body can develop seborrheic dermatitis in various places. The upper back and chest, face/forehead, creases at the base of your nose, behind your ears, navel (belly button), brows, beneath your breasts, and in the creases/bends of your arms, legs, and crotch are the areas with the most sebaceous (oil) gland activity. Seborrheic dermatitis is a chronic disorder that develops, goes away with treatment, and recurs occasionally.
Symptoms of seborrheic dermatitis includes Itchy white flakes of skin on the scalp (dandruff). When scratched, the flakes come loose, mix in with the hair, or fall onto the neck and shoulders. Moreover, red scales on the skin, pinkish plaques (thick skin) of scales on both sides of the face, flaky patches on the chest and at hairline that are shaped like a flower petal or a ring.
Historical overview
The market was analyzed qualitatively and quantitatively from 2021-2031. The seborrheic dermatitis treatment market grew at a CAGR of around 11.0% during 2021-2031. Most of the growth during this period was derived from the North America owing to the rise in the number of seborrheic dermatitis treatment industry who manufactures seborrheic dermatitis treatment product, rising disposable incomes, as well as well-established presence of domestic companies in the region.
Market Dynamics
Growth of the global seborrheic dermatitis treatment market share is majorly driven by rise in the number of autoimmune diseases such as HIV (human immunodeficiency virus), and psoriasis, technological advancement in healthcare sector and increase in the number of research activities. Increase in the number dermatological clinics and rise in number of treatment options for seborrheic dermatitis are anticipated to fuel the seborrheic dermatitis treatment market growth. For instance, different type of shampoos, lotions, gels and foams are available in market for treatment of seborrheic dermatitis. Medicated shampoos are a first-line treatment that doctors suggest to-help ease discomfort and control flaking. There are many options available over the counter (OTC) at local drug store or online. Shampoos containing selenium sulfide antifungal agents, like selenium sulfide, may help when used as little as twice a week.
In addition, rise in the adoption of prescription drugs for treatment of seborrheic dermatitis are anticipated to boost the growth of market. For instance, some of the prescription-based drugs available in the market for the treatment of seborrheic dermatitis are hydrocortisone, fluocinolone (capex, synalar), clobetasol (clobex, temovate) and desonide (desowen, desonate). In addition, rise in the adoption of over-the counter drugs due to increasing number of retail and online pharmacies are anticipated to boost the growth of seborrheic dermatitis treatment market. For instance, some of the OTC drugs available for the treatment of seborrheic dermatitis include Selsun and Exelderm (selenium sulfide), Head and Shoulders and Zincon (Zinc pyrithione), Nizoral 1% (ketoconazole) and T-Gel extra strength and DHS tar (Tar).
Moreover, rise in the awareness among the people regarding skin health and increase in disposable income are anticipated to boost the growth of market. Moreover, increase in number of dermatological clinics, retail pharmacies, hospital pharmacies and online pharmacies are anticipated to boost the growth of market. Moreover, surge in demand for anti-fungal and anti-inflammatory drug due to rise in prevalence of skin diseases escalate the growth of the market. In addition, the development and launch of advanced hospital pharmacy boost the market growth. For instance, in June 2021, the Apollo Hospitals announced the launch of Apollo Healthcare by merging the offline and online pharmacies.
In addition, increase in prevalence of skin diseases caused due to yeast called Malassezia fosters the need for anti-inflammatory, anti-fungal, and corticosteroid drug, which boosts the growth of the market. Moreover, the availability of over-the-counter drugs in retail pharmacy is one of the major factors responsible for the growth of the market. Furthermore, increase in number of hospital care centers, surge in demand for personalized medicines, rise in adoption of anti-dandruff shampoos, lotions and creams, and increase in healthcare expenditure propel the growth of the market.
Technological advancement in the field of healthcare sector is anticipated to fuel the growth of seborrheic dermatitis treatment market. Moreover, rise in the number of product approvals for new seborrheic dermatitis drugs attribute to boost the market growth. For instance, in November 2021, Aurobindo Pharma, a leading distribution channel of dermatology solutions, announced the FDA (Food and Drug Administration) approval of Prednisolone tablets USP, 1 mg for the treatment of dermatologic diseases including seborrheic dermatitis.
In addition, rise in adoption of key strategies such as collaboration, acquisition, agreement and partnership by seborrheic dermatitis treatment industry that manufacture seborrheic dermatitis treatment device fuels the growth of the market. Moreover, Dermatology is one of the leading healthcare departments across the globe as society is getting more attracted towards self-care and personality development. Advancement in this field is primary need for growth in the R&D as well as the market to fulfill the requirements of patients and provide good services and solutions. There are many emerging techniques including skin protection, software for detection of skin conditions, therapies using UV rays are used to solve the different derma issues. Many derma companies are looking forward to come-up with novel and safe procedure and treatments supported with the R & D department. Seborrheic dermatitis treatment that aims to reduce itching, inflammation and redness on the skin using different medicated forms to make skin look normal and healthy. This surges the demand for derma treatments and thus, drives the growth of the seborrheic dermatitis treatment market
On the other hand, high cost of treatment options for seborrheic dermatitis, availability of home remedies and other treatment options for seborrheic dermatitis are anticipated to restrain the growth of seborrheic dermatitis treatment market.
The COVID-19 outbreak is anticipated to have a negative impact on growth of the global seborrheic dermatitis treatment market. Most of the diagnostic cases are postpone or rescheduled due conversion of dermatological clinics, diagnostic centers into COVID hospitals. Decrease in the number of consultations for skin diseases due the COVID-19 outbreak hamper the growth of seborrheic dermatitis treatment market. As COVID-19 was highly infectious, doctors need protective equipment kit (PPE Kit) in their clinics for treatment and diagnosis purpose. Moreover, COVID-19 treatment has increased in the use of personal protective equipment kit (PPE Kit). Thus, it causes scarcity of PPE kits for diagnostic and treatment process of skin disorders which hinder the market growth. Moreover, sharp cut in disposable income of people and decrease in adoption of drugs for non-emergency treatment also restrain the market growth. There is delay, reschedule, or cancellation of outpatient visits. Interruptions and disruptions affected facilities and supply chain. In addition, decrease in number of research activities for skin treatment hinder the market growth.
Segmental Overview
The seborrheic dermatitis treatment market is segmented into dosage form, treatment, type and distribution channel. Based on dosage form the seborrheic dermatitis treatment market is segmented into shampoo, cream, ointment, tablet and others. Based on treatment the market is bifurcated into anti-inflammatory, anti-fungal, antibiotics and others. Based on type the market is divided into prescription-based drugs and over-the-counter drugs. Based on distribution channel the market is divided into hospital pharmacy, retail pharmacy and online pharmacy.
By Dosage Form: Based on dosage form, the seborrheic dermatitis treatment market share is classified into shampoo, cream, ointment, tablet and others. The cream segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to high presence of different anti-fungal, anti-inflammatory creams for treatment of seborrheic dermatitis and rise in adoption of over-the-counter creams for treatment of seborrheic dermatitis.
By Treatment: Based on treatment, it is classified into anti-inflammatory, anti-fungal, antibiotics and others. The anti-fungal segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to effectiveness of antifungal creams, lotions, gels and shampoos for treatment of seborrheic dermatitis.
By Type: Based on type, the market is classified into prescription-based drugs and over-the-counter drugs. The prescription-based drugs segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to rise in awareness among the people regarding importance of prescription-based drugs and availability of prescription-based drugs in retail and hospital pharmacy.
By Distribution Channel: Based on distribution channel, the market is classified into hospital pharmacy, retail pharmacy and online pharmacy. The hospital pharmacy segment dominated the market in 2021 and is expected to continue this trend during the forecast period, owing to increase in the prevalence of skin disorders and rise in consultations for seborrheic dermatitis.
By region: The seborrheic dermatitis treatment market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America seborrheic dermatitis treatment market size is expected to grow during the forecast period owing to rise in the number of autoimmune diseases like HIV, and psoriasis, technological advancement in the healthcare sector, well developed healthcare infrastructure. Moreover, high presence of key players who manufactures seborrheic dermatitis treatment products and high disposable income among population are anticipated to boost the growth of seborrheic dermatitis treatment market.
In addition, large number of companies are adopting business strategies such as collaboration, acquisition, partnership, agreement and business expansion for increase the product portfolio for skin treatment. Thus, this factor is anticipated to boost the growth of seborrheic dermatitis treatment market.
Seborrheic dermatitis treatment market in Asia-Pacific is expected to grow during the forecast period owing to rise in awareness among people regarding seborrheic dermatitis, increase in awareness among young population regarding physical appearance. Moreover, rise in disposable income, increase in number of dermatological clinics and rise in number professionals who treat dermatological disorders are anticipated to drive the growth of seborrheic dermatitis market in Asia-Pacific during forecast period.
COMPETITION ANALYSIS
Competitive analysis and profiles of the major players in the seborrheic dermatitis treatment market include Almirall S.A., Aurobindo Pharma Ltd., Bausch Health Companies Inc., D3 Development, Inc, F. Hoffman-La Roche AG, GlaxoSmithKline plc., Leo Pharma A/S, Lupin Limited, Medimetriks Pharmaceutical Inc. and, Sun Pharmaceutical Industries Ltd. There are some important players in the market such as Aurobindo Pharma and others. Major players have adopted product launch, product expansion and acquisition as key developmental strategies to improve the product portfolio of the seborrheic dermatitis treatment market.
Some examples of product approvals in the market
In November 2021, Aurobindo pharma limited received final approval from U.S. food and drug administration for its abbreviated new drug application prednisone tablets USP, 1mg.This product is used in seborrheic dermatitis treatment.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the seborrheic dermatitis treatment market analysis from 2021 to 2031 to identify the prevailing seborrheic dermatitis treatment market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the seborrheic dermatitis treatment market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global seborrheic dermatitis treatment market trends, key players, market segments, application areas, and market growth strategies.
Seborrheic Dermatitis Treatment Market Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 6.6 billion |
 Growth Rate | CAGR of 11% |
 Forecast period | 2021 - 2031 |
 Report Pages | 325 |
 By Dosage form |
|
 By Treatment |
|
 By Type |
|
 By Distribution channel |
|
 By Region |
|
 Key Market Players | LEO PHARMA A/S, ALMIRALL S.A., MEDIMETRICKS PHARMACEUTICAL INC, GlaxoSmithKline plc, lupin limited, Bausch Health Companies Inc., F. HOFFMAN-LA ROCHE AG, Aurobindo Pharma Ltd, SUN PHARMACEUTICAL INDUSTRIES LTD, D3 Development, Inc |
Analyst Review
Seborrheic dermatitis treatment is a treatment that is used to cure the symptoms of a skin condition caused due to stress, infection, inflammation, hormonal imbalance in the body affecting areas with most sebaceous gland activity. The market is expected to witness growth during the forecast period owing to rise in awareness among the people regarding skin care, increase in the number of seborrheic dermatitis treatment R&D activities and rise in number of dermatology clinics.
Rise in adoption of key strategies such as collaboration, acquisition, agreement, and partnership by key players who manufactures Seborrheic Dermatitis Treatment, medications fuel the growth of seborrheic dermatitis treatment market. Moreover, rise in number of product launch and product approvals for different seborrheic dermatitis treatment are anticipated to drive the market growth in forecast period. For instance, in November 2021, Aurobindo Pharma Ltd., a multinational pharmaceutical manufacturing company, received final approval from U.S. food and drug administration for its abbreviated new drug application prednisone tablets USP, 1mg.This product is used in seborrheic dermatitis treatment.
The top companies that hold the market share in seborrheic dermatitis treatment market are Almirall S.A., Aurobindo Pharma Ltd., Bausch Health Companies Inc., D3 Development, Inc, F. Hoffman-La Roche AG, GlaxoSmithKline plc., Leo Pharma A/S, Lupin Limited, Medimetriks Pharmaceutical Inc. and, Sun Pharmaceutical Industries Ltd.
Asia-Pacific is expected to register highest CAGR from 2022 to 2031, owing to rise in awareness among the people regarding availability skin disease treatment and rise in adoption of high quality anti-fungal shampoos, lotions, creams, and foams.
The key trends in the seborrheic dermatitis treatment market are rise in the number of autoimmune diseases such as HIV (human immunodeficiency virus), and psoriasis, technological advancement in healthcare sector and increase in the number of research activities.
The base year for the report is 2021.
Yes, seborrheic dermatitis treatment market market companies are profiled in the report
The total market value of seborrheic dermatitis treatment market market is $2,330.1 million in 2021.
The forecast period in the report is from 2022 to 2031
The market value of seborrheic dermatitis treatment market in 2022 was $2,584.1 million
Loading Table Of Content...
